novel biofocused anticancer therapies (IUCT/LEITAT)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namenovel biofocused anticancer therapies (IUCT/LEITAT)
Drug Alias NameNOBITAN (IUCT/LEITAT)enhanced anticancer therapy (IUCT/LEITAT)NOBITAN
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInstitut Universitari de Ciencia i Tecnologia (IUCT)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLeitatInstitut Universitari de Ciencia i Tecnologia (IUCT)
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A